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Patients’ knowledge about psoriasis and its treatment has been randomly studied previously. The aim of the study is to investigate
patients’ knowledge about psoriasis in relation to undergoing patient education in the context of climate therapy (CT).The psoriasis
knowledge questionnaire (PKQ) was used in a follow-up pre–post study design of Norwegian patients with psoriasis at the age of 20
years and older undergoing CT at Gran Canaria (Spain). Patients completed the PKQ and provided selected demographic, clinical
and health information before (T1), immediately after (T2), and 3 months after (T3) CT. Disease severity was assessed using the
psoriasis area and severity index (PASI). 254 psoriasis patients were included (74%).The PKQ score improved significantly from T1
to T2 and T3 (𝑃 < 0.001 for both comparisons). Although patient’s knowledge improved, further research should use gold standard
designs (experiments) to study the effects of educational interventions in different contexts.
1. Introduction
Knowledge about a disease and its treatment alone does
not change the attitudes and health behaviour related to
living with chronic illness. Nevertheless, knowledge about a
disease and its treatment is important for coping with the
symptoms and living well with a chronic illness. Integration
of knowledge, skills, and values enhances an individual’s
health competence, which in turn may affect the patient’s
involvement with their disease, health, work, coping, and
quality of life [1]. To our knowledge, few studies have been
published on psoriasis patients’ knowledge about the disease,
in particular in the past few decades.
Research has shown that living with psoriasis can be
difficult and can affect different aspects of quality of life
[2, 3]. Poor adherence to prescribed treatment is also a major
problem in this patients group [4, 5]. It is reasonable to
think that focusing on knowledge about the pathogenesis
and treatment of psoriasis may increase the patient’s per-
ception of control and attention to aggravating factors and
may thus increase patient’s compliance with treatment and
positive lifestyle habits. Lanigan and Layton [6] used a 22-
item knowledge questionnaire developed by Lanigan and
Farber [7] to assess the level of knowledge and information
sources used by patients with psoriasis. Although the patients
knew many core facts about psoriasis, they did not know a
number of facts about the disease, which may be valuable
in improving self-management. Renzi et al. [8] studied the
levels of participation, satisfaction, and knowledge among
patients with cutaneous psoriasis and psoriatic arthritis. The
knowledge questions were related to treatment and were
assessed by 12 correct and incorrect statements. According to
Renzi et al. [8], the level of knowledge was not high, a finding
that is consistent with previous studies [9, 10]. Insufficient
patient knowledge can represent a barrier to participation in
shared decision making [10].
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Climate therapy (CT) at Gran Canaria combines treat-
ments with sunlight and salt water to relieve symptoms and is
a treatment option for psoriasis patients in Norway [11]. The
treatment programme includes a systematic teachingmodule
to improve knowledge about psoriasis, lifestyle choices,
management of symptoms, and the impact of the disease.This
programme is based on the recognition that a patient’s health
competence is important for their involvement in the disease,
coping, quality of life, and use of health care resources. A
previous study has shown positive changes in disease severity
and health-related quality of life after CT, although these
positive changes last only for about 2months [12]. Few studies
have investigated the effect of educational interventions on
psoriasis in general and specifically with knowledge as an
outcome. However, positive effects on patients’ knowledge
have been reported [13, 14].
Although a patient’s knowledge about a disease and its
treatment is not the only factor explaining success with self-
management, it should not be overlooked in the modern
health care system, which relies on principles of shared
decision making and partnerships between doctors and
patients. Although patients’ knowledge about their disease
and treatment has been studied previously, the assessment
tools are old [6] or limited in scope; for instance, most focus
only on treatment [8] or were developed for subgroups such
as patientswith psoriatic arthritis [15].Theoverall objective of
this study was to evaluate the patients knowledge of psoriasis
in depth by investigating changes in knowledge in broad areas
related to patient education in the context of CT.The specific
aims were to
(i) describe the level of knowledge in a sample of patients
with psoriasis entering a CT programme,
(ii) investigate the associations between selected demo-
graphic, clinical factors and knowledge about psoria-
sis,
(iii) evaluate changes in knowledge in a sample of patients
with psoriasis undergoing CT (including a standard
programme of patient education).
2. Materials and Methods
2.1. Study Design and Population. The present study is a
follow-up, pre-post study design of Norwegian patients with
psoriasis at the age of 20 years and older who were offered a
3-week CT programme at Gran Canaria.The design included
three measurements over a period of 4 months. The patients
were recruited to the studywhen they arrived at the treatment
centre. They completed the questionnaire just before (T1)
and immediately after CT (T2) and again 3 months after CT
(T3). The study lasted from late April 2009 to early January
2010, and during this time 343 psoriasis patients completed
the CT programme and were eligible for the study. Of these
343 patients, 254 (74%) agreed to be included in the study.
Reasons for not willing to participate were not evaluated.
For the PKQ and the purpose of this paper, the data were
available for 253 (T1), 249 (T2), and 211 (T3) patients, resulting
in response rates of 98% (249/254) for T2 and 83% (211/254)
for T3.
The study was approved by the hospital administration
and Norwegian Social Science Data Service and was recom-
mended by the Regional Committee for Medical Research
Ethics for Southern Norway. The protocol complied with the
Declaration of Helsinki.
2.2. ClimateTherapy (CT). The 3-week CT programme com-
prised both a sun and sea treatment and patient education.
Patients received on average 80 h of sunshine during their
stay. The sun exposure was scheduled individually with
respect to skin type and ultraviolet index. They were encour-
aged to swim frequently in salt water and use moisturizing
creams. A Nordic medical team (dermatologist, nurses, and
physiotherapist) monitored the patients. Patients received
both individual and group-based education, guidance, and
daily training. Some parts were mandatory and some parts
were voluntary. The teaching programme included infor-
mation and dialogue about psoriasis pathogenesis, manifes-
tations, comorbidity, quality of life and treatment options,
physical activity, and dietary aspects. Patients also partici-
pated in group discussions focusing on living with psoriasis.
2.3. Instruments
2.3.1. Knowledge. The PKQ, which is a simple additive index,
was developed in the Norwegian dermatology context and
contains 49 statements about psoriasis. The items are shown
in Table 1. The response alternatives to each statement are
“valid,” “uncertain,” or “invalid.” A total score is calculated
by counting the number of correct answers with a possible
range of 0–49. A higher score indicates greater knowledge.
The development of the PKQ started with discussions among
the health care personnel (nurses and doctors) at a der-
matology ward about the expectations of what individuals
with psoriasis should know about their disease. The first
author (AKW) searched the literature (books and articles) on
patient information related to psoriasis. A first draft of the
questionnaire was developed from the discussions and the
literature review; this draft included 56 statements and five
response alternatives from 1 “agree” to 5 “disagree.” This draft
was presented to health care personnel, researcherswithin the
field, and patients. A pilot sample of 50 patients attending CT
completed and commented on the questionnaire through a
brief interview with ALK. After the pilot study and several
rounds of discussions and comments about the statements,
wording, and responses, a final version of 49 statements with
the three response alternatives, valid, uncertain, and invalid
was agreed upon. Cronbach’s alpha for the 49 items index was
0.84 in the present sample.
In addition to the PKQ, at T2, a single item asked the
patients to rate to what extent the CT programme had
contributed to their knowledge about psoriasis. The possible
responses were “considerably,” “some,” “little,” and “not at
all.” They were also asked to answer an open-ended question
about the reason(s) for their response.
2.3.2. Demographic and Clinical Variables. Thequestionnaire
contained questions about age, sex, marital status, level of
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Table 1: The PKQ items: percentages of correct and uncertain answers at baseline (T1).
The 49-item PKQ True/false Percentage ofcorrect answers Uncertain
(1) Once you have psoriasis, the illness will become increasingly worse. False 41 27
(2) The ways psoriasis develops vary greatly. True 91 7
(3) People with psoriasis can develop psoriatic arthritis. True 91 7
(4) With psoriasis, there is increased division of the cells in the skin. True 89 9
(5) If all signs of psoriasis are gone, you are completely cured. False 84 14
(6) The more psoriasis you have, the greater the chances for developing psoriatic
arthritis. False 30 59
(7) Scaling of the skin is the result of accumulation of dead cells. True 78 16
(8) With psoriasis, the skin feels warm because of increased blood flow in the
psoriatic lesions. True 31 48
(9) A throat infection can/may cause psoriasis. True 62 27
(10) A skin injury can/may cause psoriasis. True 71 20
(11) Taking antibiotics can/may cause psoriasis. False 11 65
(12) Environmental pollution can/may cause psoriasis. False 17 67
(13) Antimalaria and high blood pressure medicines can/may worsen psoriasis. True 11 81
(14) Stress or worry can/may exacerbate psoriasis. True 95 3
(15) Sunlight can/may exacerbate psoriasis for some people. True 51 31
(16) Diet is important to the development of psoriasis. False 7 36
(17) Laundry powder and various types of chemicals exacerbate psoriasis. False 8 55
(18) Scratching the skin can/may worsen psoriasis. True 56 31
(19) Treatment is the same for all psoriasis patients. False 79 13
(20) Treatment depends on lifestyle, the severity of psoriasis, and the location of the
lesions. True 63 23
(21) Cortisone ointment/cream may be applied only for one week at a time. False 36 29
(22) There are several types of cortisone ointments/creams with different potency
for the treatment of psoriasis. True 91 8
(23) Research shows that herbal medicines have a positive effect on psoriatic lesions. False 20 71
(24) Daivonex (calcipotriol) ointment/cream contains a substance similar to
vitamin D. True 55 42
(25) Vitamin D preparations should be applied abundantly to the lesions, but the
amount used should not exceed 100 grams per week. True 15 71
(26) All topical treatments for psoriasis can/may be applied at all skin locations over
the entire skin surface. False 43 42
(27) Phototherapy can/may increase the risk of skin cancer. True 36 47
(28) Sunlight suppresses the immune system of the skin. True 25 39
(29) Methotrexate is used in the treatment of psoriatic lesions and arthritis. True 65 34
(30) Moisturizers stop the skin’s ability to produce fatty substances, and thereby you
become dependent on using them to keep your skin moist. False 46 46
(31) There is no upper limit regarding UVB treatment for psoriasis. False 63 29
(32) Daivobet ointment contains only cortisone. False 37 52
(33) Vitamin A preparations (e.g., Neotigason) cannot be used during pregnancy. True 19 79
(34) Carbamide-containing moisturizers can/may reduce the scaling. True 43 55
(35) Creams contain more fat than ointments. False 43 43
(36) Cyclosporin (Sandimmun Neoral) affects the immune system and can be used
to treat serious cases of psoriasis. True 19 80
(37) Psoriasis located in nails is difficult to treat. True 62 36
(38) Ointment is often a better treatment for psoriasis than cream. True 52 39
(39) Salicylic acid ointment/oil is used to remove psoriasis scales of the skin and the
scalp. True 89 10
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Table 1: Continued.
The 49-item PKQ True/false Percentage ofcorrect answers Uncertain
(40) The effect of locally applied cortisone may decrease with daily use over several
months. True 61 36
(41) Enbrel/Remicade heals psoriasis. False 25 59
(42) Psoriasis is an inflammation of the skin. True 53 25
(43) Psoriasis is an infectious disease. False 53 36
(44) Psoriasis is a disease of the immune system. True 43 32
(45) Psoriasis is an allergic disease. False 67 28
(46) Women are more prone to psoriasis than men. False 46 56
(47) Psoriasis can pass between generations. True 77 21
(48) Psoriasis occurs most frequently in people older than 50 years. False 51 42
(49) Overweight, diabetes, and cardiovascular diseases occur more frequently in
people with psoriasis than in the general population. True 31 60
formal education, cohabitation, work, duration of psoriasis,
previousCT, and comorbidities. Disease severitywas assessed
using the psoriasis area and severity index (PASI). The
diagnosis of psoriatic arthritis was confirmed by patient
records.
2.4. Statistics. The SPSS PC version 19.0 was used to analyse
the data. Descriptive analyses were performed to assess the
frequency, mean, standard deviation (SD), and range of
scores (minimum to maximum). Cronbach’s alpha was used
to estimate the internal consistency of the scale (reliability).
Paired-sample 𝑡-tests were used to evaluate changes in the
PKQ score from T1 to T2 and T3. Multiple linear regression
(forward) analyses were used to identify significant associa-
tions between demographic and clinical factors (independent
variables) and the PKQ score (dependent variable) at T1. 𝑃
values <0.05 were considered significant.
3. Results
3.1. Study Population. The mean age for the sample was
47 years (range 20–80) and comprised 40% women. Sixty
percent of the sample reported <12 years of education
(primary school level), and 69% were in paid work. Forty-
four percent reported comorbidity, and the mean duration
of psoriasis was 24 years (SD = 13). Further information
about the demographic and clinical characteristics is shown
in Table 2.
3.2. The PKQ—Descriptive at T1. The percentage of correct
answers at T1 (before CT) varied greatly between the 49
PKQ items (see Table 1). The statement receiving most of the
number of correct responses (95%) was “Stress and worry
can/may exacerbate psoriasis” (item 14). The lowest percent-
age of correct answers (7%) was for the statement “Diet is
important to the development of psoriasis” (item 16). Six
other items had >80% correct answers: “The ways psoriasis
develops vary greatly” (item 2); “People with psoriasis can
develop psoriatic arthritis” (item 3); “With psoriasis, there is
increased division of cells in the skin” (item 4), “If all signs
of psoriasis are gone, you are completely cured” (item 5);
“There are several types of cortisone ointments/creams with
different potency in the treatment of psoriasis” (item 22); and
“Salicylic acid ointment/oil is used to remove psoriasis scales
of the skin and the scalp” (item 39). In addition to item 16,
eight items were answered correctly by <20% of the partici-
pants: “Taking antibiotics can/may cause psoriasis” (item 11);
“Environmental pollution can/may cause psoriasis” (item 12);
“Antimalaria and high blood pressure medication can/may
worsen psoriasis” (item 13); “Laundry powder and various
types of chemicals can/may exacerbate psoriasis” (item 17);
“Vitamin D preparations should be applied abundantly to
the lesions, but the amount used should not exceed 100
grams per week” (item 25); “Vitamin A preparations (e.g.,
Neotigason) cannot be used during pregnancy” (item 33);
and “Cyclosporin (Sandimmun Neoral) affects the immune
system and can be used to treat serious cases of psoriasis”
(item 36). For other statements, 50–60% of the answers were
correct.
On the single question asking the patients at T2 to what
extent the CT programme had improved their knowledge
about psoriasis, 62% reported considerably, 34% to some
extent, 3% little, and 1% not at all. When responding to
the open-ended question about the reason for improvement,
participants mentioned frequently the education programme
and meeting other patients.
3.3. Association between PKQ and Demographic and Clinical
Factors at T1. Results from the multiple linear regression
(forward) analysis show that sex (women), higher educational
level, higher PASI score, and previous CT were significantly
associated with greater psoriasis-related knowledge at T1
(before CT). This model explained 20% of the variance in
the PKQ score at T1. Further information is presented in
Table 3.
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Table 2: Descriptive data, 𝑛 = 254.
𝑛 Range (mean) SD 𝑛 (%)
Age, years 254 20–80 (47) 12
Years with psoriasis 245 1–60 (24) 13
BMI 251 17–49 (28) 5
Pretreatment PASI score 253 0.4–26.1 (7.5) 4.1
Posttreatment PASI score 253 0–20.6 (1.6) 2.2
Sex, women 254 102 (40)
Educational level 254
Primary school ≥ 12 years 153 (60)
University < 4 years 52 (20)
University ≥ 4 years 49 (19)
Employed, yes 254 174 (69)
Living alone, yes 250 70 (28)
Comorbidity, yes 254 111 (44)
PsA verified by doctor, yes 252 64 (25)
Previous climate therapy, yes 252 140 (55)
PKQ T1 253 5–43 (24.4) 7.0
PKQ T2 249 6–44 (29.7) 7.0
PKQ T3 211 9–43 (29.3) 7.1
BMI: body mass index, PsA: psoriasis arthritis, PASI: psoriasis area severity index, PKQ: psoriasis knowledge questionnaire, T1: before climate therapy, T2:
immediately after climate therapy, and T3: three months after climate therapy.
Table 3: Associations between demographic and clinical factors and PKQ by simple (unadjusted) and multiple (forward) (adjusted) linear
regression analysis at T1.
Patients’ level of knowledge (PKQ) (higher score indicates greater knowledge)
Unadjusted Stdandard beta
coefficient (𝑃 value)
Adjusted Stdandard beta coefficient
(𝑃 value)
Sex (1 = men; 2 = women) 0.20 (0.001) 0.25 (0.000)
Cohabitation (0 = together; 1 = alone) ns ns
Education (1–5: higher score = higher level of education) 0.25 (0.000) 0.27 (0.000)
Age (years) ns ns
BMI (higher score = higher BMI) ns ns
PASI (higher score = more severe disease) ns 0.19 (0.002)
PsA (1 = no; 2 = yes) 0.14 (0.023) ns
Comorbidity (1 = no; 2 = yes) ns ns
Previous climate therapy (1 = no; 2 = yes) 0.28 (0.000) 0.29 (0.000)
BMI: body mass index, PsA: psoriasis arthritis, PASI: psoriasis area severity index, PKQ: psoriasis knowledge questionnaire, T1: before climate therapy, and ns:
nonsignificant.
3.4. Immediate and Long-Term Changes in PKQ Score follow-
ing CT. The mean PKQ scores at the different measurement
times (T1–T3) are shown in Table 3. The scores were 24.4
(SD 7.1), 29.7 (SD 7.0), and 29.3 (SD 7.1) at T1, T2 and
T3, respectively. Paired-sample 𝑡-tests showed significant
improvements in the PKQ score (𝑃 < 0.001) from T1 (before
CT) to T2 (followup immediately after CT) and fromT1 to T3
(followup 3 months after CT).
Twelve percent of the patients had a lower PKQ score at
T2 compared with T1, and 14% of the patients had a lower
score at T3 than at T1. The PKQ score improved by 9 points
in 25% of the patients from T1 to T2 and in 19% from T1 to
T3.
4. Discussion
The present study focused on psoriasis patients’ knowledge
of broad medical domains. The patients completed the PKQ
in the context of CT. The importance of patient knowledge
in the modern health care setting is based on the philosophy
of a partnership between the patient and doctor for shared
decision making about treatment options. In the study
by Renzi et al. [10], patients with good knowledge more
frequently reported complete satisfactionwith care compared
with patients with poor knowledge.
We found large variations in knowledge between items
on the PKQ, which may be interpreted as favourable with
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regard to the questionnaire’s ability to reveal strengths and
weaknesses within a patient’s knowledge. The statement that
attracted the highest percentage of correct answers was that
stress and worry can exacerbate psoriasis (item 14), whereas
the statement with the lowest percentage of correct answers
was the statement that diet is important to the development
of psoriasis (item 16). Because knowledge profiles have been
studied rarely in relation to psoriasis, there are few studies
with which to compare our results. A study by Lanigan and
Layton [6] in 1991 found that a number of facts about the
disease were not known by patients but would be of value
in self-care. For example, 53% of patients did not know that
sunburn can exacerbate psoriasis, and 56% were unaware
that infections can aggravate the condition. A recent study
by Renzi et al. [8] found gaps in knowledge about treatments
in both psoriasis and psoriatic arthritis groups. The same
pattern has been reported in other studies [15, 16]. Our study
also identified gaps of knowledge. We believe it is important
to educate patients about their condition; as new knowledge
about psoriasis develops, the nature of the knowledge patients
need must be revised and refined.
The knowledge level improved significantly from before
to immediately after CT and remained at the same level
after 3 months, suggesting that the CT programme had an
impact. Due to the programme content, we may anticipate
some change in knowledge (education about the topics and
patients talking with health personal and fellow patients
during the CT). However, themagnitude of change is difficult
to evaluate. Additional studies in different patient education
settings for psoriasis are needed in order to decide on the
clinical significance of the findings related to change in
knowledge. Because of the lack of a control group, it is not
possible to draw conclusions about cause and effect. However,
because the patients’ knowledge was measured by factual
questions, one may assume that the CT programme, which
included education, counseling, and support from other
patients, influenced their knowledge level. This conclusion is
also supported by the responses to the open-ended questions,
which showed that most patients thought that the stay
had improved their knowledge, specifically the importance
of the courses and support from fellow patients. A study
examining the effect of an empowerment-based educational
intervention among psoriasis patients attending a medical
spa showed improved knowledge about the disease in the
experimental group, although knowledge was measured as
only one dimension of empowerment [14]. Another study
investigating the efficacy of a single educational intervention
in patients with chronic plaque psoriasis found that the
patients had better knowledge about the disease after the
intervention [13]. However, knowledge was measured by four
questions that asked patients to rate their perception of
knowledge in general and related to causes, treatment, and
biological therapies. It is possible that patients perceive their
knowledge level to be better than what would be revealed by
answering factual questions.
We found several significant associations between
selected demographic and clinical variables and knowledge.
Being a woman, living with someone, higher educational
level, having more severe disease, and previous participation
in CT were significantly related to better knowledge at
baseline. Our findings contrast with those of Lanigan and
Layton [6], Lubrano et al. [15] and Tham and Tay [16], who
reported no associations between demographic and clinical
variables and knowledge level in patients with psoriasis
or psoriatic arthritis. However, Lubrano et al. [15], found
a significant association between educational level and
knowledge. It is reasonable to expect that people with a
higher educational level are more interested in knowledge,
and perhaps this is also the case for women. Older people
and those who attended more CT may have had the disease
for longer and thereby learned more about this disease with
time. People with more severe disease may experience the
importance ofmedical knowledge in order to keep symptoms
under control.
Based on the results from both the developmental stages
of the PKQ and the empirical study, we consider the PKQ
a proper tool for measuring knowledge in the setting of
psoriasis. The instrument could be used in clinical practice
to create a patient knowledge profile to individualize patient
information and education.
Further research should use gold standard designs to
study the effects of different educational interventions on
knowledge and to evaluate the relationships between patient
knowledge, self-management skills and competence, and
quality of life.
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